![Mark Vincent](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Vincent
Fondateur chez
Sarissa, Inc.
Profil
Mark D.
Vincent is the founder of Sarissa, Inc., founded in 2000, serving as Chief Executive Officer & Director since 2011.
Dr. Vincent is currently an Associate Professor at the University of Western Ontario, a position held since 2012.
Former positions include Director at DRI Healthcare, Director-Investigational Oncology at YM BioSciences, Inc., and Independent Director at Aptose Biosciences, Inc. from 2007 to 2026.
Education includes a doctorate from the University of Cape Town, conferred in 1976.
Postes actifs de Mark Vincent
| Sociétés | Poste | Début |
|---|---|---|
Sarissa, Inc. | Fondateur | 01/01/2000 |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2008 |
Anciens postes connus de Mark Vincent
| Sociétés | Poste | Fin |
|---|---|---|
| APTOSE BIOSCIENCES INC. | Directeur/Membre du Conseil | 30/06/2026 |
DRI Healthcare
 DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors. | Directeur/Membre du Conseil | - |
YM BioSciences, Inc.
 YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Produces cancer-related drug products | Corporate Officer/Principal | - |
Formation de Mark Vincent
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Aptose Biosciences, Inc.
 Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles | Health Technology |
DRI Healthcare
DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors. | Finance |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Produces cancer-related drug products | Health Technology |
University of Western Ontario
University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cape Town
 University of Cape Town Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sarissa, Inc. |
